EVASENCE

Details for Australian Trade Mark No. 1425493 (hide)

Owner Affymax Pharma Limited a United Kingdom company

Convention US 5 April 2011 85/287171

Service Davies Collison Cave

Filing Date 17 May 2011

Classes

Class 5 Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke

Event Publications

2 June 2011 Application filed

28 July 2011 Application Accepted

10 November 2011 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1425494-SIMPLY SMARTER

1425492-deca home